PAVmed was founded by Michael J. Glennon, Lishan Aklog, Joshua R. Lamstein, Brian Justo DeGuzman in 2014.

How much funding has PAVmed raised?

PAVmed has disclosed $69.1M raised across 9 rounds.

Where is PAVmed headquartered?

PAVmed is headquartered in New York, US.

PAVmed

NASDAQ: PAVM

New York, US · Founded 2014 · Delaware corporation

Find your way into PAVmed

Paths you didn't know you had: your email and LinkedIn already hold routes to the PAVmed team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

PAVmed is a medical technology company that develops and commercializes products across medical devices, diagnostics, and digital health through its subsidiaries. It serves healthcare systems, clinicians, and patients, with subsidiaries including Lucid Diagnostics (esophageal precancer and cancer detection) and Veris Health (remote patient monitoring for cancer care).

Digital Health Healthtech Medical Devices

Founders & leadership

PAVmed was founded in 2014 by Michael J. Glennon, Lishan Aklog, Joshua R. Lamstein, and Brian Justo DeGuzman.

Michael J. Glennon Co-founder · Board Director, Vice ChairmanMichael Glennon is Director at PAVmed, a medical technology company that develops diagnostic and monitoring products through subsidiaries including Lucid Diagnostics and Veris Health. He has prior experience in medical device business development.

Lishan AklogChairman & CEO, Co-FounderChairman & CEO at Lucid Diagnostics

Joshua R. LamsteinCo-founder

Brian Justo DeGuzmanChief Technology Officer, Chief Compliance Officer & Co-FounderChief Technology Officer & Chief Compliance Officer at Lucid Diagnostics

Dennis M. McGrathPresident & CFOExecutive Officer at Lucid Diagnostics

Michael A. GordonGeneral CounselExecutive Officer at Lucid Diagnostics

Shaun O'Neil Executive Vice President & Chief Operating OfficerShaun O'Neil is Executive Officer of PAVmed, a medical technology company that develops and commercializes medical devices, diagnostics, and digital health products through subsidiaries including Lucid Diagnostics, which focuses on esophageal precancer and cancer detection.

Richard Fitzgerald Chief Financial Officer2015–2017Richard Fitzgerald is Executive Officer at PAVmed, a medical technology company with subsidiaries in diagnostics and digital health. He brings over three decades of finance and operational leadership in life sciences, including prior roles as CFO at Immunome and Sesen Bio, and earlier as CFO of PAVmed during its 2016 IPO, along with senior financial positions at Exelon Corporation and PricewaterhouseCoopers; he holds a B.S. in Business Administration and Accounting from Bucknell University.

Shaun M. O'Neil Executive Vice President & Chief Operating OfficerShaun M. O'Neil serves as Executive Vice President and Chief Operating Officer at PAVmed, a medical technology company that develops and commercializes medical devices, diagnostics, and digital health products through subsidiaries including Lucid Diagnostics and Veris Health.

Victoria T. LeeEVP and Chief Medical Officer

Board

Debra J. WhiteBoard director

Ronald M. SparksBoard director

Reported raises · per SEC filings

Form D private placements

$69.1M disclosed across 9 rounds · 2014–2026

▶$30MraisedFeb 2026 · 14 investors · Other Health Care

Rule 506(b)